The woman’s symptoms were identified as a severe cutaneous reaction triggered by the new inhalation therapy. Discontinuing the medication was imperative to halt the progression of the lesions. Blood tests and biopsy results revealed inflammation consistent with a drug-induced dermatological condition, complicating her respiratory treatment plan. Careful management and follow-up ensured her skin gradually healed without systemic damage.
This case underscores the importance of vigilance in primary care when new treatments coincide with unusual skin manifestations. Early recognition and swift intervention can prevent systemic complications and safeguard patient well-being, especially in those with chronic illnesses.
